These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1473988)

  • 1. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism.
    Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
    Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
    Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
    [No Abstract]   [Full Text] [Related]  

  • 9. Trisarubicinol, new antitumor anthracycline antibiotic.
    Yoshimoto A; Matsuzawa Y; Matsushita Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1492-4. PubMed ID: 7319909
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
    Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of new anthracyclines 10-O-rhodosaminyl beta-rhodomycinone and beta-isorhodomycinone from mild-acid treated culture of obelmycin-producing Streptomyces violaceus.
    Johdo O; Yoshioka T; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1997 Jun; 50(6):522-5. PubMed ID: 9268010
    [No Abstract]   [Full Text] [Related]  

  • 12. Anthracycline metabolites from Streptomyces violaceus A262. III. New anthracycline obelmycins produced by a variant strain SE2-2385.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1130-40. PubMed ID: 1955396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial conversion of anthracyclinones to carminomycins by a blocked mutant of Actinomadura roseoviolacea.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1989 Nov; 42(11):1698-703. PubMed ID: 2584152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maggiemycin and anhydromaggiemycin: two novel anthracyclinone antitumor antibiotics. Isolation, structures, partial synthesis and biological properties.
    Pandey RC; Toussaint MW; McGuire JC; Thomas MC
    J Antibiot (Tokyo); 1989 Nov; 42(11):1567-77. PubMed ID: 2584139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397
    [No Abstract]   [Full Text] [Related]  

  • 18. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
    Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398
    [No Abstract]   [Full Text] [Related]  

  • 20. Production of new anthracycline antibiotic betaclamycin B by microbial conversion with a specific aclacinomycin-negative mutant.
    Yoshimoto A; Johdo O; Watanabe Y; Nishida H; Okamoto R; Takeuchi T
    J Antibiot (Tokyo); 1992 Jun; 45(6):1005-7. PubMed ID: 1500340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.